Successful treatment of esophageal cancer with transhiatal esophagectomy after heart transplantation

2004 ◽  
Vol 78 (2) ◽  
pp. 702-705 ◽  
Author(s):  
Dipin Gupta ◽  
Mahender Macha ◽  
Valentino Piacentino ◽  
Arun K Singhal ◽  
Harvey F Sasken ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Heart Transplantation ◽  
Successful Treatment ◽  
Transhiatal Esophagectomy

scholarly journals Comparison of Short-term Outcome of Thoracoscopic-Laparoscopic Esophagectomy Versus Transhiatal Esophagectomy for Resectable Esophageal Cancer

2021 ◽  
Vol 11 (1) ◽  
pp. 31113.1-31113.6
Author(s):  
Touraj Asvadi Kermani ◽  
◽  
Seyed Ziaeddin Rasihashemi ◽  
Hoseinpour Feyzi ◽  
Moein Hoseinpour Feyzi ◽  
...  
Keyword(s):  
Overall Survival ◽  
Esophageal Cancer ◽  
Blood Loss ◽  
Similar Rate ◽  
Transhiatal Esophagectomy ◽  
Term Outcome ◽  
Laparoscopic Esophagectomy ◽  
Resectable Esophageal ◽  
Resectable Esophageal Cancer ◽  
One Year

Background: Esophagectomy is performed in all patients with resectable esophageal cancer. Transthoracic-Laparoscopic Esophagectomy (TLE) is a minimally invasive method and considered to be the most appropriate method. In this study, we aim to evaluate and compare the perioperative outcome, and 1-year overall survival of TLE and Transhiatal Esophagectomy (THE) approaches. Methods: In this retrospective study, we reviewed the medical records of 108 patients with esophageal cancer undergoing TLE (n=44) or THE (n=64) between 2015 and 2018. The patients were followed for one year. The intraoperative and postoperative findings, as well as 1-year overall-survival, were compared between the two groups. Results: TLE compared to THE had a longer surgery duration (278.63±33.28 vs 223.28±33.99 min, P=0.001), a higher number of dissected lymph nodes (15.06±2.95 vs 10.21±2.58, P=0.001), less blood loss (345.45±178.76 vs 585.15±294.75 mL, P<0.001), and need for transfusion (20.5% vs 45.3%, P=0.006) during surgery as well as lower ICU stay (2.59±0.77 vs 3.90±0.83 days, P<0.001) and ward stay (8.77±0.96 vs 11.42±1.71 days, P<0.001). THE had somewhat higher complication than TLE, but with no significant differences. Conclusion: TLE had a similar rate of complication to THE approach, but with lower blood loss and lower ICU and hospital stay, it is a more appropriate method for esophagectomy.

Hypertrophic cardiomyopathy and mtDNA depletion. Successful treatment with heart transplantation

2002 ◽  
Vol 12 (1) ◽  
pp. 56-59 ◽  
Author(s):  
F.M. Santorelli ◽  
M.G. Gagliardi ◽  
C. Dionisi-Vici ◽  
F. Parisi ◽  
A. Tessa ◽  
...  
Keyword(s):  
Hypertrophic Cardiomyopathy ◽  
Heart Transplantation ◽  
Successful Treatment ◽  
Mtdna Depletion

Three Elderly Patients With Lower Esophageal Cancer Successfully Treated By Transhiatal Esophagectomy Assisted by Mediastinoscopy

2000 ◽  
Vol 10 (6) ◽  
pp. 391-395 ◽  
Author(s):  
Naohiko Koide ◽  
Manabu Hiraguri ◽  
Akihito Nishio ◽  
Jun Igarashi ◽  
Hiroyuki Watanabe ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Elderly Patients ◽  
Transhiatal Esophagectomy

Mediastinoscopy-assisted Transhiatal Esophagectomy for Esophageal Cancer

2016 ◽  
Vol 26 (6) ◽  
pp. e153-e156 ◽  
Author(s):  
Tsutomu Nomura ◽  
Takeshi Matsutani ◽  
Nobutoshi Hagiwara ◽  
Itsuro Fujita ◽  
Yoshiharu Nakamura ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Transhiatal Esophagectomy

Transhiatal Esophagectomy in the Management of Perforated Esophageal Cancer

1991 ◽  
Vol 156 (11) ◽  
pp. 634-636 ◽  
Author(s):  
D. C. MacGillivray ◽  
H. B. Etienne ◽  
D. A. Snyder
Keyword(s):  
Esophageal Cancer ◽  
Transhiatal Esophagectomy

Prospective comparison of transthoracic versus transhiatal esophagectomy following neoadjuvant therapy for esophageal cancer

2007 ◽  
Vol 20 (3) ◽  
pp. 225-231 ◽  
Author(s):  
M. A. Morgan ◽  
W. G. Lewis ◽  
A. N. Hopper ◽  
X. Escofet ◽  
T. J. Havard ◽  
...  
Keyword(s):  
Esophageal Cancer ◽  
Neoadjuvant Therapy ◽  
Transhiatal Esophagectomy ◽  
Prospective Comparison

The role of circumferential resection margin in esophageal cancer: Does it influence local recurrence and survival?

2012 ◽  
Vol 30 (4_suppl) ◽  
pp. 23-23
Author(s):  
Asad Kutup ◽  
Tarik Ghadban ◽  
Yogesh Kumar Vashist ◽  
Dean Bogoevski ◽  
Jakob Robert Izbicki
Keyword(s):  
Esophageal Cancer ◽  
Local Recurrence ◽  
Median Survival ◽  
Resection Margin ◽  
Prognostic Significance ◽  
Transhiatal Esophagectomy ◽  
Resection Margins ◽  
Term Survival ◽  
Surgical Specimen ◽  
Metastatic Relapse

23 Background: Established independent prognostic factors after resection are tumor stage, tumor grade, nodal involvement, lymph node ratio and tumor infiltration of the proximal or distal resection margin in esophageal cancer. In a few series the clinical and prognostic significance of the CRM involvement have been investigated, showing conflicting results in esophageal cancer. The purpose of this study was to analyze the significance of microscopic tumor involvement of the CRM on long-term survival and local recurrence (LR) following esophagectomy in T3 esophageal cancer. Methods: Between 1993 and 2008, 146 patients, with T3 esophageal tumors had undergone potentially curative transthoracic esophagectomy (TTE) with radical lymphadenectomy of the upper abdomen and mediastinum or transhiatal esophagectomy (THE) with microscopically tumor free proximal and distal resection margins. Surgical specimen were recorded as CRM positive (CRM+) if the distance from the CRM was measured microscopically 1mm or less; otherwise it was graded as CRM negative (CRM-). None of these patients had a neoadjuvant therapy. Results: In the whole study population, median survival for CRM-- and CRM+ patients was 13 and 15 months, respectively (p=.933). LR occurred in 48 patients (32.9%). Of these, 19 (39.6%) had a positive CRM and 29 patients (60.4%) a negative CRM. Of the remaining 98 patients (67.1%) without LR, in 40 patients (40.8%) CRM was positive, while 58 patients (59.2%) had a negative CRM (p=.887). The grading and tumor localization had no significant influence on the LR (p=.181 and .163). The TTE group included 104 patients, in 68 patients (65.4%) of them CRM was negative, in 36 (34.6%) CRM was positive. The THE group included 42 patients, in 19 patients (45.2%) CRM was negative, whereas in 23 patients (54.8%) CRM was positive, respectively (p=.025). CRM involvement had no statistical significant impact on LR or metastatic relapse in either node negative tumors (p=.384) or node positive tumors (p=.653). Conclusions: After TTE a positive CRM was less seen without statistifical influence on median survival time. This study has shown that the presence of microscopic tumor of the CRM is not a significant prognostic variable.

NovelLamp-2 gene mutation and successful treatment with heart transplantation in a large family with Danon disease

2006 ◽  
Vol 33 (3) ◽  
pp. 393-397 ◽  
Author(s):  
Andoni Echaniz-Laguna ◽  
Michel Mohr ◽  
Eric Epailly ◽  
Ichizo Nishino ◽  
Philippe Charron ◽  
...  
Keyword(s):  
Heart Transplantation ◽  
Gene Mutation ◽  
Successful Treatment ◽  
Large Family ◽  
Danon Disease
Sign in / Sign up

Export Citation Format

Share Document